Latest Zaleplon Stories
NORTH KINGSTOWN, R.I., Sept.
According to the National Institutes of Health, insomnia is common, affecting one-third of adults. About 10% complain of chronic insomnia, meaning their troubles last for more than one month and occur at least three nights a week.
No single sleeping pill stands out as the best, according to a U.S. review of the newer sleep aids on the market.
Insomniacs can now try another sleeping pill for desperately needed slumber. Lunesta, from Sepracor Inc., is the latest entry into the sleep medication market, and it has the distinction of being the only such medication approved for long-term use by the U.S. Food and Drug Administration (FDA).
- An interdisciplinary study of social injustice.